'Supplemental figure s4' diaporamas de présentation

Supplemental figure s4 - PowerPoint PPT Presentation


H2B

H2B

0.5. 0.4. 0.3. HAT activity. 0.2. 2N. 4N. 0.1. R120. R90. R75. R60. R45. DNA Contents. R30. R0. Asyn. 0.0. Asyn. R0. R30. R45. R60. R75. R90. R120. Time after release from nocodazole treatment (min). Time after release from nocodazole treatment (min).

By washi
(126 views)

1752-0509-7-44-s1

1752-0509-7-44-s1

Supplemental Figure S1. Additional topological metrics of the GIL constructed from varied partitioning sizes. A. B. D. C.

By matteo
(128 views)

Papilloma skin

Papilloma skin

Cox-2 fl/fl Cox-2 Δ E. Papilloma skin. Supplemental Figure S4.

By lars-sutton
(78 views)


View Supplemental figure s4 PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Supplemental figure s4 PowerPoint presentations. You can view or download Supplemental figure s4 presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.

Recherches associées pour Supplemental figure s4
Supplemental Figure S4

Supplemental Figure S4

Supplemental Figure S4. A. . CCND3:EVLVLGKLKWDLAAVIAHDFLALILHRLSLPSDRQALVKKHAQTFLALCATDYTFAMYPPSMI E+L++ KLKW+LAA+ HDF+ L ++ + + ++KHAQTF+ALCATD F PPSM+ CCND1:ELLLVNKLKWNLAAMTPHDFIEHFLSKMPEADENKQTIRKHAQTFVALCATDVKFISNPPSMV

By fordon (64 views)

Patel et al Supplemental Figure S4

Patel et al Supplemental Figure S4

A . Patel et al Supplemental Figure S4. 4.1 ± 1.9. SK-ES-1. 13.0 ± 3.8. SK- N-MC. 0. 4. 12. RASSF1A Fold Induction with 5-AZA treatment. B . 39.5 ± 14.5. SK-ES-1. 185.5 ± 45.6. SK- N-MC. 24.3 ± 5.9. A673. 0. 100. 150. 200. 50. CALCA Fold Induction with 5-AZA treatment.

By efrem (81 views)

Figure S4

Figure S4

Figure S4. Young (GFP) Aged (WT). GFP eMHC / Hoechst.  -GFP eMHC / Hoechst. a. c. b. GFP / eMHC / Hoechst. Figure S4 Muscle regeneration in parabionts is mediated by endogenous, resident muscle stem cells, not by circulating progenitor cells.

By cassia (94 views)

Figure S4

Figure S4

A1. A2. P-Akt Ser 473. MMP-9. P-p70S6K Thr389. b -actin. b -actin. 100. 100. 100. 100. 100. 100. 250. 250. 250. 250. 250. 250. 500. 500. 500. 500. 500. 500. DMSO. DMSO. DMSO. DMSO. DMSO. DMSO. GDC-0941 nM. GDC-0941 nM. GDC-0941 nM. GDC-0941 nM. GDC-0941 nM.

By aimee (142 views)

Figure S4

Figure S4

Figure S4.

By julie (86 views)

Figure S4

Figure S4

Figure S4. +CQ. A. CQ. untreated. Pem  ITF2357. Pem  ITF2357. ITF2357. ITF2357. untreated. untreated. Pem. Pem. H1299/GFP-LC3. H1299/ptf-LC3. B. p62/SQSTM1. LC3-I LC3-II. β -actin.

By tanya-oconnor (66 views)

Figure S4

Figure S4

JURL-MK1 + dasatinib. JURL-MK1 + imatinib. MOLM-7 + dasatinib. MOLM-7 + imatinib. JURKAT + imatinib. HEL + imatinib. Figure S4.

By regan-conway (75 views)

Figure S4.

Figure S4.

Figure S4. E. F. PDX-1. NKX6.1. Fold change. Insulin. Stage of differentiation.

By wilton (77 views)